{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:37:32Z","timestamp":1791441452724,"version":"4.3.3"},"reference-count":71,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F30CA265277"],"award-info":[{"award-number":["F30CA265277"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA163649"],"award-info":[{"award-number":["R01CA163649"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA274329"],"award-info":[{"award-number":["U54CA274329"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA251151"],"award-info":[{"award-number":["R21CA251151"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM126908"],"award-info":[{"award-number":["R35GM126908"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA270234"],"award-info":[{"award-number":["R01CA270234"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Pyrimidine nucleotide biosynthesis is a druggable metabolic dependency of cancer cells, and chemotherapy agents targeting pyrimidine metabolism are the backbone of treatment for many cancers. Dihydroorotate dehydrogenase (DHODH) is an essential enzyme in the de novo pyrimidine biosynthesis pathway that can be targeted by clinically approved inhibitors. However, despite robust preclinical anticancer efficacy, DHODH inhibitors have shown limited single-agent activity in phase 1 and 2 clinical trials. Therefore, novel combination therapy strategies are necessary to realize the potential of these drugs. To search for therapeutic vulnerabilities induced by DHODH inhibition, we examined gene expression changes in cancer cells treated with the potent and selective DHODH inhibitor brequinar (BQ). This revealed that BQ treatment causes upregulation of antigen presentation pathway genes and cell surface MHC class I expression. Mechanistic studies showed that this effect is (1) strictly dependent on pyrimidine nucleotide depletion, (2) independent of canonical antigen presentation pathway transcriptional regulators, and (3) mediated by RNA polymerase II elongation control by positive transcription elongation factor B (P-TEFb). Furthermore, BQ showed impressive single-agent efficacy in the immunocompetent B16F10 melanoma model, and combination treatment with BQ and dual immune checkpoint blockade (anti-CTLA-4 plus anti-PD-1) significantly prolonged mouse survival compared to either therapy alone. Our results have important implications for the clinical development of DHODH inhibitors and provide a rationale for combination therapy with BQ and immune checkpoint blockade.<\/jats:p>","DOI":"10.7554\/elife.87292","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:07:09Z","timestamp":1684854429000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.87292","source":"Crossref","is-referenced-by-count":33,"title":["DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation"],"prefix":"10.7554","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5045-0814","authenticated-orcid":true,"given":"Nicholas J","family":"Mullen","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Surendra K","family":"Shukla","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0457zbj98","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oncology Science, University of Oklahoma Health Sciences Center","place":["Oklahoma City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Ravi","family":"Thakur","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0457zbj98","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oncology Science, University of Oklahoma Health Sciences Center","place":["Oklahoma City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-1723","authenticated-orcid":true,"given":"Sai Sundeep","family":"Kollala","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Dezhen","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Nina","family":"Chaika","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Juan F","family":"Santana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036jqmy94","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biochemistry and Molecular Biology, University of Iowa","place":["Iowa City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"William R","family":"Miklavcic","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Drew A","family":"LaBreck","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0457zbj98","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oncology Science, University of Oklahoma Health Sciences Center","place":["Oklahoma City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Jayapal Reddy","family":"Mallareddy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"}]},{"given":"David H","family":"Price","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036jqmy94","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biochemistry and Molecular Biology, University of Iowa","place":["Iowa City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5067-0203","authenticated-orcid":true,"given":"Amarnath","family":"Natarajan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Kamiya","family":"Mehla","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0457zbj98","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oncology Science, University of Oklahoma Health Sciences Center","place":["Oklahoma City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"David B","family":"Sykes","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Regenerative Medicine, Massachusetts General Hospital","place":["Boston, United States"]},{"id":[{"id":"https:\/\/ror.org\/04kj1hn59","id-type":"ROR","asserted-by":"publisher"}],"name":"Harvard Stem Cell Institute","place":["Cambridge, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Michael A","family":"Hollingsworth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-0131","authenticated-orcid":true,"given":"Pankaj K","family":"Singh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00thqtb16","id-type":"ROR","asserted-by":"publisher"}],"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center","place":["Omaha, United States"]},{"id":[{"id":"https:\/\/ror.org\/0457zbj98","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oncology Science, University of Oklahoma Health Sciences Center","place":["Oklahoma City, United States"]},{"id":[{"id":"https:\/\/ror.org\/02bmcqd02","id-type":"ROR","asserted-by":"publisher"}],"name":"OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center","place":["Oklahoma City, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cmet.2018.10.014","type":"journal-article","article-title":"Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells","volume":"29","author":"Bajzikova","year":"2019","journal-title":"Cell Metabolism"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/2159-8290.CD-16-0611","type":"journal-article","article-title":"Adaptive reprogramming of De Novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discovery"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","type":"journal-article","article-title":"BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice","volume":"278","author":"Burke","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"28345","DOI":"10.1074\/jbc.C000446200","type":"journal-article","article-title":"Flavopiridol inhibits P-TEFb and blocks HIV-1 replication","volume":"275","author":"Chao","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","type":"journal-article","article-title":"The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies","volume":"33","author":"Christian","year":"2019","journal-title":"Leukemia"},{"key":"bib6","type":"software","article-title":"Poltools","volume-title":"GitHub","author":"Collins","year":"2021","unstructured":"Collins GS. 2021. Poltools. GitHub. 928f575. https:\/\/github.com\/GeoffSCollins\/PolTools."},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071760","type":"journal-article","article-title":"MHC class i downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"bib8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190745","type":"journal-article","article-title":"SIRT1-NOX4 signaling axis regulates cancer cachexia","volume":"217","author":"Dasgupta","year":"2020","journal-title":"The Journal of Experimental Medicine"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","type":"journal-article","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nature Biotechnology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1038\/sj.onc.1201879","type":"journal-article","article-title":"Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells","volume":"16","author":"Dejardin","year":"1998","journal-title":"Oncogene"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.immuni.2020.11.002","type":"journal-article","article-title":"Genome-wide screens identify lineage- and tumor-specific genes modulating MHC-I- and MHC-II-restricted immunosurveillance of human lymphomas","volume":"54","author":"Dersh","year":"2021","journal-title":"Immunity"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","type":"journal-article","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"bib13","first-page":"4998","type":"journal-article","article-title":"Polar solvent-induced changes in membrane lipid lateral diffusion in human colon cancer cells","volume":"45","author":"Dibner","year":"1985","journal-title":"Cancer Research"},{"key":"bib14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01300","type":"journal-article","article-title":"Evolution of cancer pharmacological treatments at the turn of the third millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/clim.1999.4777","type":"journal-article","article-title":"Mechanism of action for leflunomide in rheumatoid arthritis","volume":"93","author":"Fox","year":"1999","journal-title":"Clinical Immunology"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature23465","type":"journal-article","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","type":"journal-article","article-title":"Conserved interferon-\u03b3 signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/2159-8290.CD-20-0812","type":"journal-article","article-title":"Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade","volume":"11","author":"Gu","year":"2021","journal-title":"Cancer Discovery"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00251","type":"journal-article","article-title":"Genome-wide CRISPR screening identifies jak1 deficiency as a mechanism of T-cell resistance","volume":"10","author":"Han","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","type":"journal-article","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0152","type":"journal-article","article-title":"Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma","volume":"12","author":"Kalbasi","year":"2020","journal-title":"Science Translational Medicine"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s43018-020-0106-7","type":"journal-article","article-title":"Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors","volume":"1","author":"Keshet","year":"2020","journal-title":"Nature Cancer"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128061","type":"journal-article","article-title":"Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax","volume":"43","author":"King","year":"2021","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao5563","type":"journal-article","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Science Translational Medicine"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chembiol.2018.03.005","type":"journal-article","article-title":"Dependence on the pyrimidine biosynthetic enzyme DHODH is a synthetic lethal vulnerability in mutant KRAS-driven cancers","volume":"25","author":"Koundinya","year":"2018","journal-title":"Cell Chemical Biology"},{"key":"bib26","type":"software","article-title":"Trim Galore","volume-title":"GitHub","author":"Krueger","year":"2023","unstructured":"Krueger F. 2023. Trim Galore. GitHub. v0.6. https:\/\/github.com\/FelixKrueger\/TrimGalore."},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","type":"journal-article","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biology"},{"key":"bib28","type":"software","article-title":"Bowtie","volume-title":"Github","author":"Langmead","year":"2019","unstructured":"Langmead B, Rone C. 2019. Bowtie. Github. v1.2.3. https:\/\/github.com\/BenLangmead\/bowtie."},{"key":"bib29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw7852","type":"journal-article","article-title":"Identification of DHODH as a therapeutic target in small cell lung cancer","volume":"11","author":"Li","year":"2019","journal-title":"Science Translational Medicine"},{"key":"bib30","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0721-x","type":"journal-article","article-title":"Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"Journal of Hematology & Oncology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","type":"journal-article","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","type":"journal-article","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nature Medicine"},{"key":"bib33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003678","type":"journal-article","article-title":"Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity","volume":"9","author":"Lucas-Hourani","year":"2013","journal-title":"PLOS Pathogens"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.antiviral.2018.08.012","type":"journal-article","article-title":"Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses","volume":"158","author":"Luthra","year":"2018","journal-title":"Antiviral Research"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/2159-8290.CD-16-0612","type":"journal-article","article-title":"PTEN regulates glutamine flux to pyrimidine synthesis and sensitivity to dihydroorotate dehydrogenase inhibition","volume":"7","author":"Mathur","year":"2017","journal-title":"Cancer Discovery"},{"key":"bib36","first-page":"3107","type":"journal-article","article-title":"Cytidine 5\u2019-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine","volume":"34","author":"McPartland","year":"1974","journal-title":"Cancer Research"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/nmt-2021-0014","type":"journal-article","article-title":"An updated review of teriflunomide\u2019s use in multiple sclerosis","volume":"11","author":"Miller","year":"2021","journal-title":"Neurodegenerative Disease Management"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","type":"journal-article","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nature Reviews. Cancer"},{"key":"bib39","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215981","type":"journal-article","article-title":"ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer","volume":"552","author":"Mullen","year":"2023","journal-title":"Cancer Letters"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188387","type":"journal-article","article-title":"Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor\u2019s arsenal","volume":"1874","author":"Mundry","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115071119","type":"journal-article","article-title":"Small-molecule IKK\u03b2 activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth","volume":"119","author":"Napoleon","year":"2022","journal-title":"PNAS"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1128\/MCB.01859-07","type":"journal-article","article-title":"P-TEFb is critical for the maturation of RNA polymerase II into productive elongation in vivo","volume":"28","author":"Ni","year":"2008","journal-title":"Molecular and Cellular Biology"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2015.06.032","type":"journal-article","article-title":"THZ1 reveals roles for Cdk7 in Co-transcriptional capping and pausing","volume":"59","author":"Nilson","year":"2015","journal-title":"Molecular Cell"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1038\/s41388-020-1225-4","type":"journal-article","article-title":"MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism","volume":"39","author":"Olou","year":"2020","journal-title":"Oncogene"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ccell.2020.11.009","type":"journal-article","article-title":"Immunomodulation by targeted anticancer agents","volume":"39","author":"Petroni","year":"2021","journal-title":"Cancer Cell"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","type":"journal-article","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nature Reviews. Immunology"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1124\/jpet.104.074484","type":"journal-article","article-title":"Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation","volume":"312","author":"Podolin","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1128\/MCB.20.8.2629-2634.2000","type":"journal-article","article-title":"P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II","volume":"20","author":"Price","year":"2000","journal-title":"Molecular and Cellular Biology"},{"key":"bib49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar3342","type":"journal-article","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Science Translational Medicine"},{"key":"bib50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07472-8","type":"journal-article","article-title":"Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis","volume":"9","author":"Santana-Codina","year":"2018","journal-title":"Nature Communications"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","type":"journal-article","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discovery"},{"key":"bib52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113374","type":"journal-article","article-title":"Tumor MHC expression guides first-line immunotherapy selection in melanoma","volume":"12","author":"Shklovskaya","year":"2020","journal-title":"Cancers"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"41146","DOI":"10.18632\/oncotarget.5843","type":"journal-article","article-title":"Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth","volume":"6","author":"Shukla","year":"2015","journal-title":"Oncotarget"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","type":"journal-article","article-title":"MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s42255-021-00385-9","type":"journal-article","article-title":"Cellular pyrimidine imbalance triggers mitochondrial DNA\u2013dependent innate immunity","volume":"3","author":"Sprenger","year":"2021","journal-title":"Nature Metabolism"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","type":"journal-article","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"PNAS"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","type":"journal-article","article-title":"Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia","volume":"167","author":"Sykes","year":"2016","journal-title":"Cell"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molcel.2016.03.013","type":"journal-article","article-title":"Stress from nucleotide depletion activates the transcriptional regulator HEXIM1 to suppress melanoma","volume":"62","author":"Tan","year":"2016","journal-title":"Molecular Cell"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1021\/acsmedchemlett.9b00027","type":"journal-article","article-title":"Discovery of GSK8612, a highly selective and potent TBK1 inhibitor","volume":"10","author":"Thomson","year":"2019","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","type":"journal-article","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"bib61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030738","type":"journal-article","article-title":"Review of Indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence","volume":"12","author":"Vaddepally","year":"2020","journal-title":"Cancers"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","type":"journal-article","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nature Reviews. Immunology"},{"key":"bib63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau4972","type":"journal-article","article-title":"Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells","volume":"11","author":"Wang","year":"2019","journal-title":"Science Translational Medicine"},{"key":"bib64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684961","type":"journal-article","article-title":"Targeting pyrimidine metabolism in the era of precision cancer medicine","volume":"11","author":"Wang","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","type":"journal-article","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","type":"journal-article","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"bib67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197348","type":"journal-article","article-title":"Chrysin inhibits NF-\u03baB-dependent CCL5 transcription by targeting I\u03baB kinase in the atopic dermatitis-like inflammatory microenvironment","volume":"21","author":"Yeo","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","type":"journal-article","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08830180902978120","type":"journal-article","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"International Reviews of Immunology"},{"key":"dataset1","type":"dataset","article-title":"S2-013 and CFPAC-1 cells were treated with brequinar for 16hr or 2 weeks at two different doses and bulk RNAseq was performed","volume-title":"NCBI BioProject","author":"Singh","year":"2024","unstructured":"Singh PK. 2024. S2-013 and CFPAC-1 cells were treated with brequinar for 16hr or 2 weeks at two different doses and bulk RNAseq was performed. NCBI BioProject. https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/?term=PRJNA1099696. PRJNA1099696."},{"key":"dataset2","type":"dataset","article-title":"Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription","volume-title":"NCBI Gene Expression Omnibus","author":"Zon","year":"2016","unstructured":"Zon L. 2016. Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription. NCBI Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE68053. GSE68053."}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/87292\/elife-87292-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/87292\/elife-87292-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/87292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:21:49Z","timestamp":1787566909000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/87292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":71,"alternative-id":["10.7554\/eLife.87292"],"URL":"https:\/\/doi.org\/10.7554\/elife.87292","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.03.535399","asserted-by":"subject"}],"references":[{"id-type":"accession","id":"GSE68053","asserted-by":"subject"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.87292.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.87292.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.87292.2","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"PRJNA1099696","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP87292"}}